Genomic Expression joining the "War on Cancer" Nordic in Oslo
The Economist Events declared war on cancer, and are exploring the most pressing issues in policy and financing, treatment and care across Europe, Asia, and the Americas.
On March 8th 2017 in Oslo, The Economist is bringing the battle to the Nordics to evaluate how they are contributing to the global fight against cancer.
I will discuss how diagnostics in general and our OneRNA™ test in particular can play a pivotal role in winning the war on cancer as well as reducing cost of care.
The event aims to discover pioneering approaches to cancer prevention and treatment, solutions to shortcomings in delivery, examples of best practice and opportunities for cross-border collaboration.
The participants include policy makers, top oncologists and key solution providers, enabling a fruitful dialog that can provide a foundation for expanding cross border collaboration on the war on cancer in the Nordic.
I am honored to have been invited to present one of the solutions to War on Cancer: OneRNA™
Our OneRNA™ test typically identifies a handful of already approved drugs and more than 30 clinical trials with a strong focus on immune oncology. Furthermore, OneRNACloud™ can make your existing RNA-seq data clinically actionable.
Genomic Expression is proud to be the first company to make RNA sequencing actionable in oncology.
Click here to email us regarding access to the OneRNA™ platform or book a meeting a during the conference.
Gitte Pedersen, CEO
375 Park Avenue, Suite 2607
New York City NY 10152, USA
+1 (646) 847-9290